Stock listing
KRX:456160 G2GBIO, Inc. (지투지바이오) 주가
Follow G2GBIO, Inc. into a list and get an email when it puts out news.
Share price · KRX:456160
₩36,350 KRW +2,750 (+8.2%)
Close on Nov 20, 2026
- Day range
- ₩32,900 – ₩38,650 KRWNov 20, 2026
- Volume
- 393,941 sharesNov 20, 2026
- Market cap
- ₩604.5B KRWAt the close on Nov 20, 2026 · price × 16.63M shares outstanding
- 52-week range
- ₩22,400 – ₩124,000 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩10.96B KRWMedian day 189,417 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:456160 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩36,350 | +2,750 | +8.2% | ₩33,050 | ₩38,650 | ₩32,900 | 393,941 | |
| ₩33,600 | +1,500 | +4.7% | ₩32,450 | ₩36,250 | ₩32,150 | 161,693 | |
| ₩32,100 | -800 | -2.4% | ₩32,200 | ₩32,900 | ₩30,300 | 185,822 | |
| ₩32,900 | -2,000 | -5.7% | ₩34,850 | ₩35,600 | ₩32,750 | 97,629 | |
| ₩34,900 | -1,200 | -3.3% | ₩35,500 | ₩38,300 | ₩34,250 | 231,928 | |
| ₩36,100 | -1,050 | -2.8% | ₩36,850 | ₩37,800 | ₩35,350 | 147,739 | |
| ₩37,150 | +2,050 | +5.8% | ₩34,950 | ₩38,350 | ₩34,700 | 207,188 | |
| ₩35,100 | +4,050 | +13.0% | ₩32,150 | ₩35,900 | ₩31,450 | 287,372 | |
| ₩31,050 | +850 | +2.8% | ₩29,800 | ₩31,350 | ₩28,000 | 258,392 | |
| ₩30,200 | -3,650 | -10.8% | ₩30,450 | ₩31,000 | ₩29,150 | 334,674 | |
| ₩33,850 | +2,100 | +6.6% | ₩34,200 | ₩37,150 | ₩33,350 | 653,139 | |
| ₩31,750 | -700 | -2.2% | ₩32,100 | ₩32,800 | ₩29,350 | 375,039 | |
| ₩32,450 | -3,750 | -10.4% | ₩35,700 | ₩35,700 | ₩32,100 | 291,722 | |
| ₩36,200 | +600 | +1.7% | ₩36,100 | ₩38,200 | ₩35,850 | 285,371 | |
| ₩35,600 | -1,000 | -2.7% | ₩36,950 | ₩37,300 | ₩34,500 | 205,829 | |
| ₩36,600 | -1,300 | -3.4% | ₩39,800 | ₩40,600 | ₩35,850 | 394,695 | |
| ₩37,900 | -1,250 | -3.2% | ₩38,400 | ₩40,250 | ₩36,650 | 661,061 | |
| ₩39,150 | -6,050 | -13.4% | ₩46,000 | ₩46,000 | ₩38,900 | 1,085,582 | |
| ₩45,200 | -4,500 | -9.1% | ₩48,700 | ₩52,200 | ₩44,200 | 580,992 | |
| ₩49,700 | +8,500 | +20.6% | ₩42,050 | ₩50,600 | ₩41,150 | 1,308,334 | |
| ₩41,200 | -900 | -2.1% | ₩41,100 | ₩45,200 | ₩40,250 | 669,818 | |
| ₩42,100 | +5,100 | +13.8% | ₩42,500 | ₩45,000 | ₩41,400 | 1,125,446 | |
| ₩37,000 | +4,800 | +14.9% | ₩38,000 | ₩39,200 | ₩34,500 | 652,011 | |
| ₩32,200 | +1,050 | +3.4% | ₩29,850 | ₩32,350 | ₩29,500 | 104,227 | |
| ₩31,150 | +600 | +2.0% | ₩30,600 | ₩33,650 | ₩30,200 | 151,551 | |
| ₩30,550 | -2,300 | -7.0% | ₩30,800 | ₩32,100 | ₩29,750 | 165,664 | |
| ₩32,850 | -300 | -0.9% | ₩33,550 | ₩34,050 | ₩32,150 | 116,796 | |
| ₩33,150 | -4,350 | -11.6% | ₩36,150 | ₩36,150 | ₩32,300 | 312,730 | |
| ₩37,500 | -4,500 | -10.7% | ₩41,700 | ₩42,900 | ₩37,100 | 247,683 | |
| ₩42,000 | -2,700 | -6.0% | ₩43,150 | ₩44,800 | ₩40,700 | 205,775 | |
| ₩44,700 | +800 | +1.8% | ₩44,550 | ₩45,150 | ₩42,700 | 264,507 | |
| ₩43,900 | +300 | +0.7% | ₩43,200 | ₩44,300 | ₩41,050 | 268,329 | |
| ₩43,600 | +100 | +0.2% | ₩42,800 | ₩44,250 | ₩42,400 | 276,910 | |
| ₩43,500 | +8,150 | +23.1% | ₩35,250 | ₩45,150 | ₩34,650 | 672,572 | |
| ₩35,350 | +1,450 | +4.3% | ₩34,450 | ₩35,950 | ₩33,350 | 123,562 | |
| ₩33,900 | -850 | -2.4% | ₩34,350 | ₩34,950 | ₩33,150 | 129,410 | |
| ₩34,750 | +2,700 | +8.4% | ₩32,400 | ₩36,350 | ₩32,050 | 297,931 | |
| ₩32,050 | +150 | +0.5% | ₩31,900 | ₩33,400 | ₩31,900 | 81,131 | |
| ₩31,900 | -200 | -0.6% | ₩32,150 | ₩32,500 | ₩31,550 | 97,411 | |
| ₩32,100 | +200 | +0.6% | ₩32,050 | ₩32,550 | ₩31,750 | 65,601 | |
| ₩31,900 | -1,100 | -3.3% | ₩32,700 | ₩33,000 | ₩31,500 | 162,999 | |
| ₩33,000 | 0 | 0.0% | ₩33,000 | ₩34,050 | ₩32,550 | 90,024 | |
| ₩33,000 | -1,500 | -4.3% | ₩33,700 | ₩34,700 | ₩32,500 | 191,089 | |
| ₩34,500 | +2,900 | +9.2% | ₩36,250 | ₩38,900 | ₩33,700 | 851,128 | |
| ₩31,600 | -1,400 | -4.2% | ₩32,050 | ₩32,700 | ₩31,400 | 129,182 | |
| ₩33,000 | -1,200 | -3.5% | ₩32,800 | ₩33,350 | ₩32,300 | 125,216 | |
| ₩34,200 | -800 | -2.3% | ₩34,500 | ₩34,950 | ₩32,300 | 178,718 | |
| ₩35,000 | -2,250 | -6.0% | ₩36,600 | ₩37,150 | ₩35,000 | 191,907 | |
| ₩37,250 | -1,050 | -2.7% | ₩38,100 | ₩39,900 | ₩37,250 | 80,116 | |
| ₩38,300 | +350 | +0.9% | ₩38,250 | ₩39,300 | ₩37,550 | 48,458 | |
| ₩37,950 | +2,050 | +5.7% | ₩36,050 | ₩38,350 | ₩35,750 | 74,023 | |
| ₩35,900 | -1,150 | -3.1% | ₩37,550 | ₩38,100 | ₩35,300 | 65,319 | |
| ₩37,050 | -1,550 | -4.0% | ₩37,400 | ₩39,900 | ₩36,700 | 117,055 | |
| ₩38,600 | -2,750 | -6.7% | ₩40,850 | ₩41,100 | ₩38,100 | 136,010 | |
| ₩41,350 | -2,300 | -5.3% | ₩42,150 | ₩42,150 | ₩39,250 | 193,380 | |
| ₩43,650 | +2,400 | +5.8% | ₩41,650 | ₩43,950 | ₩39,800 | 151,038 | |
| ₩41,250 | -500 | -1.2% | ₩40,600 | ₩42,000 | ₩40,000 | 113,256 | |
| ₩41,750 | +4,250 | +11.3% | ₩38,000 | ₩42,100 | ₩37,500 | 187,744 | |
| ₩37,500 | -450 | -1.2% | ₩37,700 | ₩37,800 | ₩35,250 | 102,059 | |
| ₩37,950 | +550 | +1.5% | ₩37,550 | ₩40,400 | ₩37,500 | 155,539 | |
| ₩37,400 | -3,550 | -8.7% | ₩40,500 | ₩40,500 | ₩36,850 | 109,585 | |
| ₩40,950 | -100 | -0.2% | ₩43,350 | ₩43,950 | ₩40,750 | 119,721 |
Splits
1 split · KRX:456160 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 3-for-1 | Split |
- Ticker
- KRX:456160
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- KRX
- Currency
- KRW
What changed lately
Latest deck · Apr 20, 2026
Investor Presentation (April 2026)
Investor deck · 25 slides
G2GBIO, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- Decks
- 1 deck · latest Apr 20, 2026
Valuation
EV/sales 176× against a median of 16.2×: the highest of 6 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩389.0B KRW
- P/E
- Loss
- EV/sales
- 176×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 4.3×
- Gross margin
- 36.2%
- Operating margin
- −568.7%
- Net margin
- −793.7%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| G2GBIO, Inc. · KRX:456160 | US$451.8M | US$290.8M | n/a | 176× | n/a | 4.3× | −793.7% | 0.0× | n/a |
| BlossomHill Therapeutics, Inc. · NASDAQ:BLSM | US$461.2M | US$259.4M | n/a | n/a | n/a | 2.2× | n/a | 0.1× | n/a |
| Neurogene Inc. · NASDAQ:NGNE | US$458.5M | US$106.4M | n/a | n/a | n/a | 1.3× | n/a | 0.0× | 1.47 |
| Assembly Biosciences, Inc. · NASDAQ:ASMB | US$454.4M | US$142.3M | n/a | 2.1× | n/a | 1.5× | −16.6% | 0.0× | 1.00 |
| Shattuck Labs, Inc. · NASDAQ:STTK | US$454.2M | US$260.4M | n/a | n/a | n/a | 2.4× | n/a | 0.0× | 1.10 |
| DiaMedica Therapeutics Inc. · NASDAQ:DMAC | US$445.1M | US$410.4M | n/a | n/a | n/a | 15.5× | n/a | 0.0× | 1.67 |
| CytomX Therapeutics, Inc. · NASDAQ:CTMX | US$442.5M | US$98.96M | n/a | 7.0× | n/a | 1.6× | −609.0% | 0.0× | 1.21 |
| Capricor Therapeutics, Inc. · NASDAQ:CAPR | US$441.3M | US$335.9M | n/a | n/a | n/a | 2.1× | n/a | 0.4× | 0.94 |
| Hansa Biopharma AB · OMXSTO:HNSA | US$440.3M | US$487.4M | n/a | 26.3× | n/a | n/a | −406.5% | n/a | n/a |
| Shanghai MicuRx Pharmaceutical Co., Ltd. Class A · SSE:688373 | US$438.3M | US$407.2M | n/a | 16.2× | n/a | 19.4× | −57.0% | 0.9× | n/a |
| Hyundai Bioscience Co. Ltd. · KRX:048410 | US$437.9M | US$411.3M | n/a | 166× | n/a | 5.7× | −861.5% | 0.1× | n/a |
| Median of the others | US$443.8M | US$298.2M | 16.2× | 2.2× | −406.5% | 0.0× | 1.16 |
Team and board
| Officer | Role |
|---|---|
| Heeyong Lee | CEO |
| Mark Tracy | President of Tracy BioConsulting |
| Eunyoung Seol | Head of R&D |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (April 2026) | Investor deck | 25 slides | Apr 20, 2026 |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | 423.1M | 768.9M |
| Cost of revenue | 456.6M | 578.6M |
| Gross profit | -33.5M | 190.3M |
| Research and development | 8.09B | 7.67B |
| Selling, general and administrative | 1.31B | 1.00B |
| Operating income | -12.2B | -10.8B |
| Depreciation and amortization | 1.60B | 1.83B |
| EBITDA | -10.6B | -8.93B |
| Interest expense | 707.1M | 2.44B |
| Income before tax | -12.1B | -83.3B |
| Net income | -12.1B | -83.3B |
| Earnings per share, basic | -736.11 | -5,172.03 |
Balance sheet
| Line | FY2025 | FY2024 |
|---|---|---|
| Cash and equivalents | 7.98B | 10.0B |
| Short-term investments | 44.2B | 16.2M |
| Receivables | 416.8M | 36.7M |
| Current assets | 53.3B | 10.7B |
| Total assets | 67.7B | 25.3B |
| Current liabilities | 7.25B | 141.7B |
| Long-term debt | 916.7M | 1.42B |
| Total liabilities | 9.41B | 144.9B |
| Shareholders' equity | 58.3B | -119.5B |
| Shares outstanding | 16.4M | 16.1M |
Cash flow
| Line | FY2025 | FY2024 |
|---|---|---|
| Cash from operations | -13.9B | -7.97B |
| Capital spending | -324.0M | -583.7M |
| Free cash flow | -14.2B | -8.55B |
| Change in cash | -2.04B | -1.63B |
Cap table
Built by 6ix from G2GBIO, Inc.’s releases
- Common shares
- 16,629,426
- Fully diluted
- 16,629,426
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 16,629,426 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 16,629,426 |
Log in to ask 6ix AI your own questions about G2GBIO, Inc.